Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice.

Pinzon-Charry, Alberto; McPhun, Virginia; Kienzle, Vivian; Hirunpetcharat, Chakrit; Engwerda, Christian; McCarthy, James; Good, Michael F

Pinzon-Charry, Alberto; McPhun, Virginia; Kienzle, Vivian; Hirunpetcharat, Chakrit; Engwerda, Christian; McCarthy, James; Good, Michael F.

Affiliation

Pinzon-Charry A; Molecular Immunology Laboratory and Australian Centre for Vaccine Development, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Brisbane, Queensland, Australia.

J Clin Invest ; 120(8): 2967-78, 2010 Aug.

Article in En | MEDLINE | ID: mdl-20628205

Subject(s)

Adjuvants, Immunologic/pharmacology; CD4-Positive T-Lymphocytes/immunology; Malaria Vaccines/immunology; Malaria/immunology; Oligodeoxyribonucleotides/pharmacology; Animals; Cross Reactions; Female; Immunization; Immunologic Memory; Interferon-gamma/biosynthesis; Interleukin-2/biosynthesis; Mice; Mice, Inbred BALB C; Vaccines, Inactivated/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligodeoxyribonucleotides / CD4-Positive T-Lymphocytes / Adjuvants, Immunologic / Malaria Vaccines / Malaria Limits: Animals Language: En Journal: J Clin Invest Year: 2010 Document type: Article Affiliation country: Australia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google